Gyeonggi-do, South Korea

Yearin Jun



Average Co-Inventor Count = 22.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Hwaseong-si, KR (2023)
  • Gyeonggi-do, KR (2023 - 2024)

Company Filing History:


Years Active: 2023-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yearin Jun: Innovator in Pharmaceutical Compounds

Introduction

Yearin Jun is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target metabolic diseases and related disorders. With a total of 3 patents to his name, Yearin Jun is recognized for his innovative approaches to drug development.

Latest Patents

One of Yearin Jun's latest patents is focused on GLP-1 receptor agonists. This patent discloses novel compounds of Chemical Formula 1, including their optical isomers and pharmaceutically acceptable salts. These compounds exhibit excellent activity as GLP-1 receptor agonists, demonstrating remarkable glucose tolerance. This positions them as potential therapeutic agents for metabolic diseases, while also showcasing excellent pharmacological safety for cardiovascular systems.

Another significant patent involves substituted pyrazolo[1,5-a]pyrimidines as CFTR modulators. This disclosure provides CFTR modulator and phosphodiesterase 4 (PDE4) inhibitor compounds. These compounds can modulate CFTR functionality and offer methods for treating eye diseases and CFTR-related indications. Additionally, the patent outlines methods for inhibiting PDE4 in biological systems, which can be beneficial for treating inflammatory diseases.

Career Highlights

Yearin Jun is currently employed at Il Dong Pharmaceutical Co., Ltd., where he continues to innovate and develop new pharmaceutical compounds. His work has contributed to advancements in the treatment of various metabolic and inflammatory diseases.

Collaborations

Yearin Jun collaborates with talented coworkers, including Kyung Mi An and Jin Hee Lee. Their combined expertise enhances the research and development efforts at Il Dong Pharmaceutical Co., Ltd.

Conclusion

Yearin Jun is a prominent inventor whose work in pharmaceutical compounds has the potential to significantly impact the treatment of metabolic diseases. His innovative patents reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…